⌘K

Login Start Free

Home/Filings/4/0001209191-21-020777

4//SEC Filing

Dubin Glenn 4

Accession 0001209191-21-020777

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 4:17 PM ET

Size

5.3 KB

Accession

0001209191-21-020777

Insider Transaction Report

Form 4

Period: 2021-03-12

C4 Therapeutics, Inc.CCCC

Director

Transactions

Award
Stock Option (Right to Buy)
2021-03-12+41,200→ 41,200 total
Exercise: $44.64Exp: 2031-03-11→ Common Stock (41,200 underlying)

Footnotes (1)

[F1]One-third of this option shall vest and become exercisable on March 12, 2022, with the remainder vesting in eight equal quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001308597

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 4:17 PM ET
Size: 5.3 KB

View on SEC.gov